Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

Contributed by: Business Wire

Tags

Biotechnology

Pharmaceutical

Health

Other Health

Viatris, Inc

More Like This

PR Newswire associated0

MYONEX CLOSES CREAPHARM ACQUISITION EXPANDING GLOBAL SERVICES

Myonex to Acquire Creapharm’s Clinical & Commercial Packaging and Bioservices Business

PR Newswire associated0

ACQUISITION OF ARGATROBAN BUSINESS IN EUROPE

Ambio Announces US FDA Approval of a Generic Version of Forteo® (Teriparatide Injection) for Its Partner Apotex

Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer

Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca

PR Newswire associated0

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition

PR Newswire associated0

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries